LYPD3 and neoplasm: For example, CoCl2-treated tumour cell-derived exosomes which contained C4.4A (Ly6/PLAUR domain-containing protein 3), α6β4 integrin and MMP-14 inhibited keratinocyte migration through degradation of laminin 332 resulting in delayed wound closure [111].